Results 1 to 10 of about 30 (26)
Research and Practice in Thrombosis and Haemostasis, Volume 6, Issue S1, October 2022.
europepmc +2 more sources
Background: Many genetic mutations causing severe reduction or defect in GPIIb (CD41) and/or GPIIIa (CD61) receptors in Glanzmann Thrombasthenia (G.T.).
Hala O. Hassan +3 more
doaj +6 more sources
Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report. [PDF]
Mayne ES +4 more
europepmc +1 more source
Glanzmann thrombasthenia in a child manifesting after dengue infection. [PDF]
Muhammed S +3 more
europepmc +1 more source
cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets. [PDF]
Makhoul S +6 more
europepmc +1 more source
Thromboelastography Reference Values for Third-Trimester Healthy Obstetric Patients in Northern Mexico. [PDF]
Alvarado-Ramos S +2 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment
Expert Review of Hematology, 2012Alan T Nurden, Xavier Pillois
exaly
Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment
Blood Reviews, 2002J Caen, S Bellucci
exaly

